Understanding how blood flows through the heart during various arrhythmias is essential for diagnosing and treating cardiac conditions. Modern simulation techniques allow researchers and clinicians to visualize these complex hemodynamic processes with unprecedented detail, revealing critical insights that static imaging or simple pressure measurements cannot provide. By combining computational fluid dynamics, electrophysiological models, and high-resolution 3D imaging, these simulations offer a dynamic window into the heart’s behavior under abnormal rhythms, guiding therapeutic decisions and improving patient outcomes.

What Are Cardiac Arrhythmias?

Cardiac arrhythmias are disorders of the heart’s electrical system that cause irregular heartbeats. They can manifest as tachycardias (fast heart rates), bradycardias (slow heart rates), or chaotic rhythms such as fibrillation. While some arrhythmias are benign, others significantly impair cardiac output and elevate the risk of stroke, heart failure, or sudden cardiac death. Common types include:

  • Atrial fibrillation (AFib) – the most prevalent sustained arrhythmia, characterized by rapid, disorganized electrical activity in the atria.
  • Ventricular tachycardia (VT) – a fast rhythm originating in the ventricles, often associated with structural heart disease.
  • Atrial flutter – a regular but rapid atrial contraction pattern that can degrade filling of the ventricles.
  • Sinus bradycardia – a slow heart rate that may be physiological in athletes but can cause symptoms if excessive.
  • Premature ventricular contractions (PVCs) – extra beats that disrupt rhythm and can lead to more serious arrhythmias in susceptible hearts.

Simulating Blood Flow During Arrhythmias

Simulating blood flow in arrhythmic hearts requires integrating anatomical geometry, material properties of cardiac tissues, electrical activation sequences, and fluid dynamics. These models reconstruct how blood moves through chambers and valves under abnormal timing and contraction patterns, revealing phenomena invisible to conventional diagnostic tools. The core methodologies used in such simulations are outlined below.

Computational Fluid Dynamics (CFD)

CFD solves the Navier-Stokes equations that govern fluid motion, applied to the blood within a patient-specific or idealized heart geometry. Boundary conditions are set by measured or modeled pressure and flow waveforms derived from clinical data (echocardiography, catheterization). In arrhythmia simulations, the timing and amplitude of chamber contractions are altered to reflect the disrupted electrical activation. CFD can quantify velocity fields, shear stress on the endocardium, vorticity patterns, and regions of stagnant flow that predispose to thrombus formation. Advanced CFD models also incorporate fluid‑structure interaction (FSI) to simulate how compliant vessel walls and valves respond to blood flow.

Electrophysiological Modeling

Electrical activation governs the mechanical contraction of the heart. Electrophysiological models use the bidomain or monodomain equations to simulate propagation of action potentials through the myocardium. For arrhythmias, these models recreate reentrant circuits (e.g., in AFL) or chaotic wavefronts (as in AF). The output—timing and location of depolarization—is coupled to a mechanical model of contraction, which then drives the motion of the heart walls and valves. This coupling ensures that blood flow simulations reflect the actual mechanical consequences of the electrical disorder. Such multiphysics modeling is essential for understanding how a particular arrhythmia affects ejection fraction, filling pressures, and regional wall stress.

3D Imaging and Reconstruction

Accurate geometry is a prerequisite for meaningful CFD results. High-resolution imaging techniques—CT, MRI, and 3D echocardiography—provide detailed anatomical data of the heart chambers, valves, and great vessels. Image segmentation algorithms reconstruct the surfaces and volumes, which are then meshed into finite elements or finite volumes. For arrhythmia simulations, time-resolved imaging (4D flow MRI) can validate the simulated flow patterns and offer ground-truth data for model calibration. The combination of patient-specific anatomy and personalized electrical activation makes simulations highly relevant for clinical decision-making.

Key Insights from Simulation Studies

Simulations have produced a wealth of quantitative findings that directly inform our understanding of arrhythmia pathophysiology. Below are three critical areas where modeling has provided unique insight.

Altered Flow Patterns and Turbulence

During sinus rhythm, blood flows through the heart in a largely laminar fashion, with organized vortices that promote efficient mixing and chamber filling. In contrast, arrhythmias dramatically alter these patterns. In atrial fibrillation, the loss of coordinated atrial contraction leads to chaotic flow patterns within the atria, especially in the left atrial appendage (LAA). CFD studies show that during AF, flow in the LAA becomes highly turbulent with rapid changes in velocity direction, reducing the ability to wash out blood and increasing the risk of clot formation. Ventricular tachycardia can generate high-velocity jets across the mitral or tricuspid valves, but the asynchronous contraction of ventricular segments creates swirling flow that impairs the ejection fraction. Turbulent flow also increases shear stress on the endocardium, potentially contributing to endothelial injury and thrombogenicity.

Blood Stasis and Thrombus Formation

One of the most clinically important consequences of arrhythmias is the increased risk of thromboembolism, particularly stroke in patients with AF. Simulations have precisely quantified the regions and conditions of blood stasis—areas where blood dwells long enough for coagulation factors to activate. In the LAA, which is the primary source of emboli in nonvalvular AF, CFD reveals that low wall shear stress (<1 Pa) and prolonged residence time correlate with thrombus formation. Patient-specific models can identify which individuals have higher risk profiles, guiding anticoagulation therapy. Studies have shown that stasis patterns differ between paroxysmal and persistent AF, and simulations help explain why even short episodes of AF can lead to clot formation.

Impact on Cardiac Function and Remodeling

Beyond acute hemodynamic effects, arrhythmias impose chronic mechanical stresses that lead to structural remodeling. For example, persistent atrial fibrillation increases atrial wall stress due to rapid and irregular contraction, promoting fibrosis and dilation. Simulations that couple hemodynamics with tissue growth laws can predict adverse remodeling over months to years. Similarly, in ventricular arrhythmias, the dyssynchronous contraction pattern causes regions of high wall stress that predispose to hypertrophy and eventually heart failure. These modeling insights are now being used to risk‑stratify patients and to design more effective ablation strategies.

Clinical Applications and Treatment Implications

The knowledge gained from blood flow simulations is translating into tangible improvements in patient care. Three major clinical domains are illustrated below.

Guiding Catheter Ablation

Ablation procedures for atrial fibrillation often target the pulmonary vein ostia, but the optimum lesion set may depend on the patient’s individual flow dynamics. Simulation can predict how ablation alters flow patterns and whether certain regions become more prone to stasis post‑procedure. Researchers have used CFD to compare the hemodynamic effects of different ablation strategies (e.g., wide antral vs. segmental), finding that leaving small gaps between lesions may paradoxically increase vortex formation and stasis. These insights help electrophysiologists choose lesion locations that minimize the risk of post‑ablation thrombus.

Anticoagulation Decisions

Simulation-derived metrics such as washout time and shear stress are being explored as biomarkers to refine stroke risk stratification beyond traditional CHA₂DS₂‑VASc scores. By identifying patients with the highest likelihood of LAA thrombus, clinicians can tailor anticoagulation intensity. Studies have demonstrated that simulation predictions of thrombus presence have high sensitivity and specificity when validated against transesophageal echocardiography. As computing power increases, real‑time simulation may become part of routine clinical workflow for AF patients.

Development of Cardiac Devices

Left atrial appendage occlusion devices are commonly used to reduce stroke risk in AF patients who cannot tolerate anticoagulation. CFD simulations help engineers design and optimize device shapes to achieve complete sealing and prevent leakage around the device, which could otherwise leave a nidus for clot formation. Similarly, ventricular assist devices (VADs) benefit from blood flow simulations to minimize shear‑induced platelet activation and thrombosis. The same multiphysics approach used in arrhythmia simulations is now applied to iterative device design, shortening development cycles and improving safety. External guidelines from the FDA’s medical device guidance now encourage such modeling as part of the regulatory submission process.

Future Directions in Cardiac Simulation

The field is advancing rapidly, driven by improvements in computational power, machine learning, and multi‑scale modeling. Emerging trends include:

  • Machine learning surrogate models – fast neural network approximations of CFD that can provide real‑time flow predictions in the catheterization lab.
  • Digital twins – personalized virtual replicas of a patient’s heart that continuously update with clinical data, enabling predictive simulation of ablation outcomes or drug effects.
  • Multi‑scale modeling – integrating molecular‑level data on platelet activation and clotting cascades with organ‑level hemodynamics to simulate thrombus formation in silico.
  • 4D flow MRI validation – non‑invasive imaging techniques that directly measure velocity fields, closing the loop between simulation and observation.

A recent comprehensive review in Progress in Biophysics and Molecular Biology highlights how these tools are enabling personalized medicine for cardiac arrhythmias. The coordinated effort of engineers, clinicians, and data scientists promises to make simulation a routine component of arrhythmia management within the coming decade.

Conclusion

Simulating blood flow during different cardiac arrhythmias has moved beyond academic curiosity to become a practical asset in understanding heart function and guiding therapy. By integrating computational fluid dynamics, electrophysiology, and high‑resolution imaging, these models reveal the mechanical consequences of electrical chaos—turbulence, stasis, and altered wall stress—that underlie the morbidity of conditions like atrial fibrillation and ventricular tachycardia. The insights directly inform ablation planning, anticoagulation decisions, and device design, while future innovations in digital twins and machine learning promise to make simulation even more clinically actionable. As the technology matures, it will play an increasingly central role in delivering precise, patient‑specific care to individuals with cardiac arrhythmias.